23 May 2013
Keywords: Genzyme, Sanofi, Isis Pharma, Kynamro, HoFH, Cholesterol disorder
Article | 02 April 2012
Biotech firm Genzyme, a subsidiary of French drug major Sanofi (Euronext: SAN), has submitted a New Drug Application to the ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
2 April 2012
1 April 2012
© 2013 thepharmaletter.com